ClinVar Miner

Submissions for variant NM_017617.5(NOTCH1):c.2153A>G (p.Asn718Ser)

dbSNP: rs1843232044
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Baylor Genetics RCV001330761 SCV001522551 likely pathogenic Adams-Oliver syndrome 5 2020-03-17 criteria provided, single submitter clinical testing This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].
Labcorp Genetics (formerly Invitae), Labcorp RCV001330761 SCV003459881 uncertain significance Adams-Oliver syndrome 5 2021-12-18 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt NOTCH1 protein function. ClinVar contains an entry for this variant (Variation ID: 1029477). This missense change has been observed in individual(s) with NOTCH1-related conditions (PMID: 29555671). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 718 of the NOTCH1 protein (p.Asn718Ser).
GeneDx RCV003324827 SCV004030529 uncertain significance not provided 2023-02-24 criteria provided, single submitter clinical testing Reported in a proband with mitral valve stenosis and the mother with a ventricular septal defect (Szot et al., 2018); Functional studies demonstrate receptor maturation and signaling are similar to wildtype (Chapman et al., 2020); In silico analysis supports that this missense variant does not alter protein structure/function; However, in silico analysis supports a deleterious effect on splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29555671, 31813956)
Juno Genomics, Hangzhou Juno Genomics, Inc RCV004796608 SCV005416027 uncertain significance Aortic valve disease 1; Adams-Oliver syndrome 5 criteria provided, single submitter clinical testing PM2_Supporting+PS2_Supporting+PS4_Supporting+PP2+PP4

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.